| |||||||||||||||||||||||||||||||||||
Study ID | Study | Experiment Name | Experiment Notes | Strain Ont ID | Strain | Sex | Age | # of Animals | Sample Notes | Clinical Measurement Ont ID | Phenotype | Formula | Clinical Measurement Notes | Average Type | Value | Units | SEM | SD | Method Ont ID | Method | Method Site | Method Duration | Method Notes | Post Insult Type | Post Insult Time Value | Post Insult Time Unit | Conditions | Record ID | |||||||
689 | Shepel LA, et al., Genetics 1998 May;149(1):289-99 | mammary gland integrity trait | RS:0000982 | WF | female | 200 days to 181 days | 53 | CMO:0000343 | mammary tumor number | 3.62 | 0.2679 | 1.95 | MMO:0000344 | necropsy | 0.0 | from 126 to 140 days | DMBA oral gavage | 126 | days | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (between 126 and 140 days) | 66100 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (between 126 and 140 days) |